New! Sign up for our free email newsletter.
Science News
from research organizations

Drug activates virus against cancer

Date:
October 15, 2013
Source:
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Summary:
Scientists have discovered that a drug called valproic acid increases the effectiveness of parvoviruses that are used against cancer. In some cases, pancreatic and cervical tumors that had been transplanted to rats completely regressed after treatment with a combination of the virus and an agent. The drug makes the viruses replicate more rapidly and improves their capacity to kill cancer cells.
Share:
FULL STORY

Parvoviruses cause no harm in humans, but they can attack and kill cancer cells. Since 1992, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been studying these viruses with the aim of developing a viral therapy to treat glioblastomas, a type of aggressively growing brain cancer. A clinical trial has been conducted since 2011 at the Heidelberg University Neurosurgery Hospital to test the safety of treating cancer patients with the parvovirus H-1.

"We obtained impressive results in preclinical trials with parvovirus H-1 in brain tumors," says Dr. Antonio Marchini, a virologist at DKFZ. "However, the oncolytic effect of the viruses is weaker in other cancers. Therefore, we are searching for ways to increase the therapeutic potential of the viruses."

In doing so, the virologists also tested valproic acid, a drug belonging to a group of drugs called HDAC inhibitors. The effect of these inhibitors is to raise the transcription of many genes that have been chemically silenced. Valproic acid is commonly used to treat epilepsy and has also proven effective in treating specific types of cancer.

The researchers initially used a combination of parvoviruses and valproic acid to treat tumor cells that had been obtained from cervical and pancreatic carcinomas and raised in the culture dish. In both types of cancer, the drug raised the rate of virus-induced cell death; in some cases, the cancer cells were even completely eliminated.

The encouraging results obtained in cultured cells were confirmed in cervical and pancreatic tumors that had been transplanted to rats. After the animals were treated with a combination of parvoviruses and valproic acid, in some cases the tumors regressed completely and animals remained free of recurrences over a one-year period. In contrast, animals treated with the same virus dose without the drug displayed no regression, not even when a 20-times higher dose of viruses was administered.

The virologists were also able to unravel the molecular mechanism by which valproic acid assists parvoviruses in fighting cancer: Treatment with the drug activates a viral protein called NS1, which is toxic. This helps the viruses replicate more rapidly and kill cancer cells more effectively.

"The synergistic effect of a combination of parvoviruses and valproic acid enables us to deliver both the viruses and the drug at low doses, which prevents severe side effects," Marchini explains. "The results are encouraging us to carry out further tests of this combination therapy. We believe it has the potential to arrest tumor growth in severe cases of cancer."


Story Source:

Materials provided by German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). Note: Content may be edited for style and length.


Journal Reference:

  1. Junwei Li, Serena Bonifati, Georgi Hristov, Tiina Marttila, Severine Valmary-Degano,Sven Stanzel, Martina Schnölzer, Christiane Mougin, Marc Aprahamian, Svitlana P. Grekova, Zahari Raykov, Jean Rommelaere and Antonio Marchini. Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas. EMBO Molecular Medicine, October 2013

Cite This Page:

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). "Drug activates virus against cancer." ScienceDaily. ScienceDaily, 15 October 2013. <www.sciencedaily.com/releases/2013/10/131015123834.htm>.
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). (2013, October 15). Drug activates virus against cancer. ScienceDaily. Retrieved December 13, 2024 from www.sciencedaily.com/releases/2013/10/131015123834.htm
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). "Drug activates virus against cancer." ScienceDaily. www.sciencedaily.com/releases/2013/10/131015123834.htm (accessed December 13, 2024).

Explore More

from ScienceDaily

RELATED STORIES